Skip to main content
SpringerLink
Log in
Book cover

Antibiotic Policies pp 81–89Cite as

The Role of Antibiotic Policies in Controlling VRE

  • Chapter
  • First Online:

  • 1778 Accesses

Abstract

Antibiotic resistance is an emerging problem. Vancomycin resistant enterococci pose a significant problem in many areas of the world. The emergence of VRE has been linked to the use of glycopeptides both in environmental as well as clinical setting. Transmission of VRE between patients is associated with poor compliance with infection control policies. Antibiotic formulary intervention has shown to be of some benefit in reducing the rate of acquisition of VRE within the health care setting. This review focuses on the extent to which antibiotic policies help control the growing trend of VRE and suggests some interventions that could be potentially rewarding.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aarestrup FM, Seyfarth AM, Emborg HD et al (2001). Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in denmark. Antimicrob Agents Chemother 45: 2054-2059.

    Article  PubMed  CAS  Google Scholar 

  • Anglim AM, Klym B, Byers KE et al (1997). Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant enterococcus faecium. Arch Intern Med 157: 1132-1136.

    Article  PubMed  CAS  Google Scholar 

  • Bates J (1997). Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. J Hosp Infect 37: 89-101.

    Article  PubMed  CAS  Google Scholar 

  • Bonhoeffer S, Lipsitch M, Levin BR (1997). Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 94: 12106-12111.

    Article  PubMed  CAS  Google Scholar 

  • Bonten MJ, Willems R, Weinstein RA (2001). Vancomycin-resistant enterococci: Why are they here, and where do they come from? Lancet Infect Dis 1: 314-25.

    Article  PubMed  CAS  Google Scholar 

  • Bradley SJ, Wilson AL, Allen MC et al (1999). The control of hyperendemic glycopeptide-resistant enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother 43: 261-266.

    Article  PubMed  CAS  Google Scholar 

  • Brown DF, Hope R, Livermore DM et al (2008). Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and ireland, 2001-06. J Antimicrob Chemother 62 Suppl 2: ii75-85.

    Article  PubMed  CAS  Google Scholar 

  • Cookson BD, Macrae MB, Barrett SP et al (2006). Guidelines for the control of glycopeptide-resistant enterococci in hospitals. J Hosp Infect 62: 6-21.

    Article  PubMed  CAS  Google Scholar 

  • D’Agata EM, Horn MA, Webb GF (2002). The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci. J Infect Dis 185: 766-773.

    Article  PubMed  Google Scholar 

  • Donskey CJ, Hanrahan JA, Hutton RA et al (2000). Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 181: 1830-1833.

    Article  PubMed  CAS  Google Scholar 

  • Dryden MS, Cooke J, Davey P (2009). Antibiotic stewardship--more education and regulation not more availability? J Antimicrob Chemother 64: 885-888.

    Article  PubMed  CAS  Google Scholar 

  • Gould IM (2002). Antibiotic policies and control of resistance. Curr Opin Infect Dis 15: 395-400.

    Article  PubMed  Google Scholar 

  • Gould IM (2009). Controversies in infection: Infection control or antibiotic stewardship to control healthcare-acquired infection? J Hosp Infect 73: 386-391.

    Article  PubMed  CAS  Google Scholar 

  • Hidron AI, Schuetz AN, Nolte FS et al (2008). Daptomycin resistance in enterococcus faecalis prosthetic valve endocarditis. J Antimicrob Chemother 61: 1394-1396.

    Article  PubMed  CAS  Google Scholar 

  • Kawalec M, Kedzierska J, Gajda A et al (2007). Hospital outbreak of vancomycin-resistant enterococci caused by a single clone of enterococcus raffinosus and several clones of enterococcus faecium. Clin Microbiol Infect 13: 893-901.

    Article  PubMed  CAS  Google Scholar 

  • Klare I, Badstubner D, Konstabel C et al (1999). Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 5: 45-52.

    Article  PubMed  CAS  Google Scholar 

  • Kumarasamy KK, Toleman MA, Walsh TR et al (2010). Emergence of a new antibiotic resistance mechanism in india, pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597-602.

    Article  PubMed  CAS  Google Scholar 

  • Kurup A, Chlebicki MP, Ling ML et al (2008). Control of a hospital-wide vancomycin-resistant enterococci outbreak. Am J Infect Control 36: 206-211.

    Article  PubMed  Google Scholar 

  • Larson EL, Quiros D, Giblin T et al (2007). Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates. Am J Crit Care 16: 110-120.

    PubMed  Google Scholar 

  • Lautenbach E, LaRosa LA, Marr AM et al (2003). Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: Impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 36: 440-446.

    Article  PubMed  CAS  Google Scholar 

  • Lopez Marti MG, Jhaveri R (2009). Bacteremia caused by an enterococcus faecalis isolate with high-level linezolid resistance in a teenager with crohn’s disease. Pediatr Infect Dis J 28: 663-664.

    Article  Google Scholar 

  • McGowan JE (2004). Debate-guidelines for control of glycopeptide-resistant enterococci (GRE) have not yet worked. J Hosp Infect 57: 281-284.

    Article  PubMed  CAS  Google Scholar 

  • Morris-Downes M, Smyth EG, Moore J et al (2010). Surveillance and endemic vancomycin-resistant enterococci: Some success in control is possible. J Hosp Infect 75: 228-233.

    Article  PubMed  CAS  Google Scholar 

  • Muto CA, Giannetta ET, Durbin LJ et al (2002). Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol 23: 429-435.

    Article  PubMed  Google Scholar 

  • Ozorowski T, Kawalec M, Zaleska M et al (2009). The effect of an antibiotic policy on the control of vancomycin-resistant enterococci outbreak and on the resistance patterns of bacteria isolated from the blood of patients in a hematology unit. Pol Arch Med Wewn 119: 712-718.

    PubMed  Google Scholar 

  • Pearman JW (2006). Lowbury lecture: The western australian experience with vancomycin-resistant enterococci - from disaster to ongoing control. J Hosp Infect 63: 14-26.

    Article  PubMed  CAS  Google Scholar 

  • Pereira GH, Muller PR, Zanella RC et al (2010). Outbreak of vancomycin-resistant enterococci in a tertiary hospital: The lack of effect of measures directed mainly by surveillance cultures and differences in response between enterococcus faecium and enterococcus faecalis. Am J Infect Control 38: 406-409.

    Article  PubMed  Google Scholar 

  • Quale J, Landman D, Saurina G et al (1996). Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 23: 1020-1025.

    Article  PubMed  CAS  Google Scholar 

  • Reilly JS, Stewart S, Christie P et al (2010). Universal screening for meticillin-resistant staphylococcus aureus: Interim results from the NHS scotland pathfinder project. J Hosp Infect 74: 35-41.

    Article  PubMed  CAS  Google Scholar 

  • Richardson LP, Wiseman SW, Malani PN et al (2000). Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff. Microb Drug Resist 6: 327-330.

    Article  PubMed  CAS  Google Scholar 

  • Shaikh ZH, Osting CA, Hanna HA et al (2002). Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J Hosp Infect 51: 52-58.

    Article  PubMed  CAS  Google Scholar 

  • Vonberg RP, Kuijper EJ, Wilcox MH et al (2008). Infection control measures to limit the spread of clostridium difficile. Clin Microbiol Infect Suppl 5: 2-20.

    Article  Google Scholar 

  • Weber SG, Huang SS, Oriola S, et al (2007). Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the joint SHEA and APIC task force. Infect Control Hosp Epidemiol 28: 249-260.

    Article  PubMed  Google Scholar 

  • Werner G, Coque TM, Hammerum AM, et al (2008). Emergence and spread of vancomycin resistance among enterococci in europe. Euro Surveill. 13: 19046.

    PubMed  Google Scholar 

  • Winston LG, Charlebois ED, Pang S et al (2004). Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci. Am J Infect Control 32: 462-469.

    Article  PubMed  Google Scholar 

  • Worth LJ, Thursky KA, Seymour JF et al (2007). Vancomycin-resistant enterococcus faecium infection in patients with hematologic malignancy: Patients with acute myeloid leukemia are at high-risk. Eur J Haematol 79: 226-233.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. NHS Ayrshire and Arran, Crosshouse Hospital, Lister Street, KA2 0BE, Kilmarnock, Scotland, UK

    Abhijit M. Bal (Consultant Microbiologist and Honorary Clinical Senior Lecturer)

Authors
  1. Abhijit M. Bal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abhijit M. Bal .

Editor information

Editors and Affiliations

  1. Medical School, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom

    Ian M. Gould

  2. University Hospital Nijmegen, Nijmegen, Netherlands

    Jos W.M. van der Meer

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bal, A.M. (2012). The Role of Antibiotic Policies in Controlling VRE. In: Gould, I., van der Meer, J. (eds) Antibiotic Policies. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1734-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1734-8_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1733-1

  • Online ISBN: 978-1-4419-1734-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation